TABLE 1.
Protein group (expected in virions)a | Protein | MWb | Size (aa)c | No. of unique peptidesd | % Coveragee | % of totalf | Total no. of proteins |
---|---|---|---|---|---|---|---|
Capsid | |||||||
UL6 (+) | 74.1 | 676 | 1 | 2.5 | |||
UL15 (?) | Terminase | 80.9 | 735 | − | NA | ||
UL17 (+) | 74.6 | 703 | 10 | 23.8 | |||
UL18 (+) | VP23 | 34.3 | 318 | 15 | 65.7 | ||
UL19 (+) | VP5/ICP5 | 149.1 | 1,374 | 54 | 59.5 | ||
UL25 (+) | 62.7 | 580 | 8 | 19.5 | |||
UL26 protease | VP24 (+) | 26.6 | 247 | 7 | 41.3 | ||
VP21 (−) | 37.3 | 363 | − | NA | |||
COOH termini (−) | 2.6 | 25 | − | NA | |||
UL26.5 | VP22a (−) | 31.2 | 304 | − | NA | ||
COOH termini (−) | 2.6 | 25 | − | NA | |||
UL28 (?) | ICP18.5 | 85.6 | 785 | − | NA | ||
UL33 (?) | 14.4 | 130 | − | NA | |||
UL35 (+) | VP26 | 12.1 | 112 | 3 | 39.3 | ||
UL38 (+) | VP19C | 50.3 | 465 | 9 | 23.9 | ||
Total | 107 | 26.7 | 8 | ||||
Envelope | |||||||
UL1 (+) | gL | 24.9 | 224 | 4 | 24.6 | ||
UL10 (+) | gM | 51.4 | 473 | 2 | 11.2 | ||
UL20 (+) | 24.2 | 222 | − | NA | |||
UL22 (+) | gH | 90.4 | 838 | 11 | 18.7 | ||
UL27 (+) | gB | 100.3 | 904 | 22 | 30.2 | ||
UL34 (−) | 29.8 | 275 | − | NA | |||
UL43 (?) | 44.9 | 434 | − | NA | |||
UL44 (+) | gC | 55.0 | 511 | 7 | 26.6 | ||
UL45 (+) | 18.2 | 172 | 5 | 39.0 | |||
UL49A (+) | gN | 9.2 | 91 | − | NA | ||
UL53 (?) | gK | 37.6 | 338 | − | NA | ||
UL56 (+) | 21.2 | 197 | 2 | 22.8 | |||
US4 (+) | gG | 25.2 | 238 | 2 | 3.8 | ||
US5 (?) | gJ | 9.6 | 92 | − | NA | ||
US6 (+) | gD | 43.3 | 394 | 7 | 23.2 | ||
US7 (+) | gI | 41.4 | 390 | 4 | 16.7 | ||
US8 (+) | gE | 59.1 | 550 | 9 | 18.4 | ||
US8A (?) | 16.8 | 159 | NA | ||||
US9 (+) | 10.0 | 90 | 1 | 37.8 | |||
Total | 76 | 19 | 12g | ||||
Tegument | |||||||
RL1 (+) | ICP34.5 | 26.2 | 248 | 1 | 3.4 | ||
RL2 (?) | ICP0 | 78.5 | 776 | 10 | 21.3 | ||
RS1 (?) | ICP4 | 132.8 | 1,298 | 20 | 22.6 | ||
UL4 (−) | 78.2 | 718 | − | NA | |||
UL7 (?) | 33.1 | 296 | 4 | 25.0 | |||
UL11 (+) | 10.5 | 96 | 2 | 20.8 | |||
UL13 (+) | 57.2 | 518 | 3 | 10.0 | |||
UL14 (+) | 23.9 | 219 | 1 | 10.5 | |||
UL16 (+) | 40.4 | 373 | 7 | 32.4 | |||
UL21 (+) | 57.6 | 535 | 9 | 27.5 | |||
UL23 (?) | TK | 41.0 | 376 | 1 | 4.4 | ||
UL31 (−) | 34.0 | 306 | − | NA | |||
UL36 (+) | Large tegument | 335.9 | 3,164 | 42 | 20.7 | ||
UL37 (+) | ICP32 | 120.6 | 1,123 | 22 | 33.2 | ||
UL41 (+) | Vhs | 54.9 | 489 | 9 | 30.1 | ||
UL46 (+) | VP11/12 | 78.2 | 718 | 16 | 34.3 | ||
UL47 (+) | VP13/14 | 73.8 | 693 | 25 | 51.2 | ||
UL48 (+) | VP16/ICP25 | 54.3 | 490 | 15 | 45.5 | ||
UL49 (+) | VP22 | 32.3 | 301 | 8 | 39.5 | ||
UL50 (?) | dUTPase | 39.1 | 371 | 6 | 26.7 | ||
UL51 (+) | 25.5 | 244 | 4 | 27.0 | |||
UL55 (?) | 20.5 | 186 | 4 | 37.6 | |||
US2 (+) | 32.5 | 291 | 5 | 15.6 | |||
US3 (+) | 52.8 | 481 | 1 | 6.7 | |||
US10 (+) | 34.1 | 312 | 3 | 13.7 | |||
US11 (+) | 17.8 | 161 | − | NA | |||
Total | 218 | 54.4 | 23 | ||||
Other | |||||||
UL2 (−) | 36.3 | 334 | − | NA | |||
UL3 (−) | 25.6 | 235 | − | NA | |||
UL5 (−) | 98.7 | 882 | − | NA | |||
UL8 (−) | 79.9 | 750 | − | NA | |||
UL9 (−) | 94.3 | 851 | − | NA | |||
UL12 (−) | 67.5 | 626 | − | NA | |||
UL24 (?) | 29.5 | 269 | − | NA | |||
UL29 (−) | ICP8 | 128.4 | 1,196 | − | NA | ||
UL30 (−) | 136.4 | 1,235 | − | NA | |||
UL32 (−) | 64.0 | 596 | − | NA | |||
UL39 (−) | ICP6/10 | 124.1 | 1,137 | − | NA | ||
UL40 (−) | 38.0 | 340 | − | NA | |||
UL42 (−) | 51.2 | 488 | − | NA | |||
UL52 (−) | 114.4 | 1,058 | − | NA | |||
UL54 (−) | ICP27 | 55.3 | 512 | − | NA | ||
US1 (−) | ICP22 | 46.5 | 420 | − | NA | ||
US12 (−) | ICP47 | 9.8 | 88 | − | NA |
Localization is based on that described in references 2 and 56. +, expected; −, not expected; ?, uncertain.
MW, estimated molecular weight (103).
aa, amino acids.
−, no peptides found.
Values shown are the percentages of coverage of proteins by peptides. NA, not applicable.
Relative peptide abundance.
Thirteen proteins if UL20 is included (Table 2, MRM data).